Cilostazol for Prevention of Recurrent Stroke Trial

The goal of this clinical trial is to learn whether adding cilostazol to aspirin or clopidogrel prevents stroke and heart attack in people who have had a stroke or mini-stroke.

NCT Number	NCT07174414
Lead Sponsor	Stanford University Collaborators: National Institute of Neurological Disorders and Stroke (NINDS), Yale University, University of Cincinnati, Medical University of South Carolina
Conditions	Stroke Recurrence, Myocardial Infarction, Vascular Death, Ischemic Stroke, TIA (Transient Ischemic Attack), Stroke (CVA) or Transient Ischemic Attack, Recurrent Stroke
Enrollment	2,000 participants
Start Date	2026-08
Primary Completion	2031-07 (estimated)
Study Completion	2031-07 (estimated)
Updated on ClinicalTrials.gov	2025-09-16